98 - Women in ID Breakfast: “SHE for SHE”: A Masterclass in Supporting Other Women in ID

Friday, October 18, 2024

7:00 AM – 8:30 AM US PT

Location: JW Marriott - Platinum Ballroom A-D

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1 hours of MOC Credit
CNE Credits: Maximum of 1 hours of ANCC Credit
ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Interactive Moderator(s)

Wendy Armstrong, MD (she/her/hers)

Professor of Medicine
Emory University
Atlanta, GA, United States
KB

Kristina Bryant, MD

Professor
University of Louisville
Louisville, KY, United States

Moderator(s)

Laila Woc-Colburn, MD (she/her/hers)

Associate Professor, Division of Infectious Disease
Emory University School of Medicine
Decatur, GA, United States
Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA

Field Medical Officer
Centers for Disease Control & Prevention & Einstein/ Montefiore
New York, NY, United States

Panelist(s)

Kari Simonsen, MD, MBA (she/her/hers)

Professor and Chair, Pediatrics
Pediatrics
University of Nebraska Medical Center
Omaha, NE, United States
Nada Fadul, MD (she/her/hers)

Professor & Assistant Dean
University of Nebraska Medical Center
Omaha, NE, United States
Angela Caliendo, MD, PhD (she/her/hers)

Executive Vice Chair, Department of Medicine
Medicine/Infectious Diseases
Alpert Medical School of Brown University
Providence, RI, United States
Rita Rojas-Fermin, MD,FIDSA

Coordinator of ID department & Program ID Fellowship director
Hospital General de la Plaza de la Salud
Santo Domingo, Distrito Nacional, Dominican Republic

Disclosure(s):

Wendy Armstrong, MD: No financial relationships to disclose

Kristina A. Bryant, MD: Enanta Pharmaceuticals: Grant/Research Support (Ongoing); Gilead Biosciences: Grant/Research Support (Terminated, June 22, 2023); Oxford Univerity Press: Royalties (Ongoing); Pediatric News: Honoraria (Ongoing); Pfizer, Inc.: Grant/Research Support (Terminated, October 7, 2022)

Laila Woc-Colburn, MD: No financial relationships to disclose

Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA: No financial relationships to disclose

Kari Simonsen, MD, MBA: AstraZeneca: Grant/Research Support (Terminated, December 31, 2023); Melinta Therapuetics: Grant/Research Support (Ongoing); Pfizer, Inc.: Grant/Research Support (Terminated, April 30, 2024)

Nada A. Fadul, MD: ViiV Healthcare/GSK: Grant/Research Support (Ongoing)

Angela M. Caliendo, MD, PhD: Beckman Coulter: Advisor/Consultant; Danaher/Cepheid: Advisor/Consultant; First Light: Advisor/Consultant; Hologic: Grant/Research Support; ID Connect: Advisor/Consultant; Lab Simply: Advisor/Consultant; UP to Date: Reviewer; Visby: Advisor/Consultant

Rita A. Rojas-Fermin, MD,FIDSA: KitePharma, a Gilead company: Grant/Research Support (Terminated); Pfizer, Inc.: Advisor/Consultant (Terminated), Honoraria (Terminated)

Learning Objectives:

At the conclusion of this session, participants will be able to:

identify actionable strategies to support and uplift women colleagues in the field of infectious diseases, including but not limited to mentorship, networking, and advocacy;
analyze the importance of fostering a supportive culture and environment for women in different roles within infectious diseases, and evaluate the potential impact on professional development and career advancement;
use a personalized action plan for implementing inclusive practices and initiatives that promote the empowerment and success of women in infectious diseases, both in the short and long term.